Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.60 |
| ▸ | GBA1 | P04062 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15241174 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL4661857 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL15060852 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL4955369 | 1.00 | — | — | |
| SCHEMBL6383256 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL6276387 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL2456824 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL6273599 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL972535 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 | |
| SCHEMBL15240966 | 1.00 | DNM1 (0.60) | DNM1GBA1TSHRTHRBCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281661-A1 | EMULSIONS FOR USE IN AIR FRESHENERS DEVICES | SYMRISE AG (DE) | 2025-09-11 | — | — | US | disclosed |
| US-20220387268-A1 | OIL-IN-WATER MACROEMULSION | SYMRISE AG (DE) | 2022-12-08 | — | — | US | disclosed |
| WO-2020233773-A1 | OIL-IN-WATER MACROEMULSION | SYMRISE AG (DE) | 2020-11-26 | — | — | WO | disclosed |
| US-8969278-B2 | Composition with surface modifying properties | ECOLAB USA INC. (US) | 2015-03-03 | — | — | US | disclosed |
| EP-2606725-A1 | Phenol derivatives as antimicrobial agents | Symrise AG (DE) | 2013-06-26 | — | — | EP | disclosed |
| US-20130156708-A1 | PHENOL DERIVATIVES AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2013-06-20 | — | — | US | disclosed |
| US-20120138089-A1 | COMPOSITION WITH SURFACE MODIFYING PROPERTIES | ECOLAB USA INC. (US) | 2012-06-07 | — | — | US | disclosed |
| US-8093195-B2 | Composition with surface modifying properties | ECOLAB USA INC. (US) | 2012-01-10 | — | — | US | disclosed |
| EP-1945746-B1 | COMPOSITION WITH SURFACE MODIFYING PROPERTIES | ECOLAB INC (US) | 2010-02-10 | — | — | EP | disclosed |
| US-20090007936-A1 | Composition with Surface Modifying Properties | ECOLAB USA INC. | 2009-01-08 | — | — | US | disclosed |
| EP-1945746-A1 | COMPOSITION WITH SURFACE MODIFYING PROPERTIES | ECOLAB, INC. (US) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007054126-A1 | COMPOSITION WITH SURFACE MODIFYING PROPERTIES | ECOLAB INC. (US) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156708-A1 | PHENOL DERIVATIVES AS ANTIMICROBIAL AGENTS | TYR, TH, COMT | DNM1 147/4885GBA1 4233/4885TSHR 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.